2.01
Nexalin Technology Inc stock is traded at $2.01, with a volume of 107.80K.
It is up +5.79% in the last 24 hours and down -25.83% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$1.90
Open:
$1.84
24h Volume:
107.80K
Relative Volume:
0.39
Market Cap:
$25.28M
Revenue:
$128.60K
Net Income/Loss:
$-4.60M
P/E Ratio:
-3.1905
EPS:
-0.63
Net Cash Flow:
$-3.74M
1W Performance:
-3.83%
1M Performance:
-25.83%
6M Performance:
+222.17%
1Y Performance:
-29.97%
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NXL
Nexalin Technology Inc
|
2.01 | 25.28M | 128.60K | -4.60M | -3.74M | -0.63 |
![]()
ABT
Abbott Laboratories
|
131.93 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Nexalin Technology Inc Stock (NXL) Latest News
Nexalin begins clinical trial for brain stimulation therapy By Investing.com - Investing.com Australia
Nexalin begins clinical trial for brain stimulation therapy - Investing.com India
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial - The Manila Times
Revolutionary Brain Treatment: Nexalin Launches PTSD Trial at UCSD with AI-Powered Home Therapy - Stock Titan
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3 - GlobeNewswire
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3 - The Manila Times
Revolutionary Brain Tech Targets $537B Market: Nexalin CEO Reveals Growth Strategy - Stock Titan
Nexalin Technology (NASDAQ:NXL) Upgraded at Maxim Group - The AM Reporter
Nexalin Technology (NASDAQ:NXL) Upgraded to “Buy” at Maxim Group - Defense World
Maxim Group Upgrades Nexalin Technology (NXL) - Nasdaq
Nexalin Technology, Inc. SEC 10-K Report - TradingView
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
Nexalin Technology’s Senior VP Makes a Bold Stock Purchase - TipRanks
Nexalin technology’s Sr. VP Carolyn Shelton acquires $13,200 in stock - Investing.com India
Nexalin technology’s Sr. VP Carolyn Shelton acquires $13,200 in stock By Investing.com - Investing.com UK
Nexalin Technology Stock Price, Quotes and Forecasts | NASDAQ:NXL - Benzinga
Nexalin Technology, Inc. Receives USPTO Notice of Allowance for Patent on Innovative Treatment Method for Opioid and Substance Use Disorders - Nasdaq
Nexalin Technology Receives Notice of Allowance from the - GlobeNewswire
Could This Newly Patented Technology Transform How We Treat Addiction? - StockTitan
UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD - Yahoo Finance
Nexalin Technology Announces Initiation of Patient - GlobeNewswire
Nexalin Technology, Inc. Launches Clinical Trial for HALO™ Clarity Device to Treat Mild Traumatic Brain Injury and PTSD at UCSD - Nasdaq
Nexalin Technology announces initiation of patient recruitment in UCSD study - TipRanks
Can Nexalin's Brain Stimulation Technology Transform PTSD Treatment? UCSD Trial Now Recruiting Patients - StockTitan
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board - EIN News
Nexalin Technology Appoints General Wesley Clark to Military & Government Advisory Board - citybiz
Can NATO's Former Supreme Commander Help Nexalin Crack the Military Mental Health Market? - StockTitan
Nexalin Secures UCSD IRB Approval For Use Of HALO Clarity In PTSD And MTBI Clinical Studies - Nasdaq
Nexalin Technology Announces UCSD IRB Approval for use of - GlobeNewswire
Nexalin Technology Announces UCSD IRB Approval For Use Of HALO Clarity In Clinical Trials For mTBI And PTSD Treatment - Marketscreener.com
Nexalin Technology Says Halo Clarity Headset Clinical Testing Gets UCSD Institutional Review Board Approval - Marketscreener.com
Nexalin Technology, Inc. Receives IRB Approval for UCSD Clinical Trials of HALO™ Clarity Headset in Treating mTBI and PTSD - Nasdaq
Revolutionary Brain Treatment Device Enters Military PTSD Trials at UCSDPotential Breakthrough for Veterans - StockTitan
10,000 Shares in Nexalin Technology, Inc. (NASDAQ:NXL) Bought by Kingsview Wealth Management LLC - Defense World
Nexalin Technology Inc [NASDAQ: NXL] Sees Decrease in Stock Value - Knox Daily
Nexalin technology's chief medical officer buys $3,100 in shares - MSN
Nexalin Technology Inc’s latest rating changes from various analysts - Knox Daily
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition - GlobeNewswire
Nexalin Technology, Inc. Appointed Industry Co-Chair of National Traumatic Brain Injury Registry Coalition - Nasdaq
Nexalin (NXL) Secures Leadership Role in $4.5B Brain Injury MarketKey Details Investors Should See - StockTitan
Nexalin Technology announces effective registration statement - MSN
Nexalin Technology announces effective registration statement By Investing.com - Investing.com UK
Nexalin Technology Inc (NXL) Stock: A Year of Highs and Lows - The InvestChronicle
Nexalin Technology Inc (NXL) Becoming More Attractive for Investors - Knox Daily
Nexalin Technology announces publication of study of DIFS technology - MSN
Can you still get a good price for Nexalin Technology Inc (NXL) Shares at this point? - US Post News
Nexalin technology's chief medical officer buys $2,980 in common stock - MSN
Nexalin technology's chief medical officer buys $2,980 in common stock By Investing.com - Investing.com South Africa
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexalin Technology Inc Stock (NXL) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
Owens David | Chief Medical Officer |
Oct 28 '24 |
Buy |
2.19 |
500 |
1,095 |
148,293 |
Owens David | Chief Medical Officer |
Aug 13 '24 |
Buy |
0.95 |
1,000 |
950 |
147,793 |
Owens David | Chief Medical Officer |
Jun 28 '24 |
Buy |
1.75 |
1,000 |
1,750 |
146,793 |
Owens David | Chief Medical Officer |
Jun 18 '24 |
Buy |
0.71 |
1,619 |
1,149 |
145,793 |
Owens David | Chief Medical Officer |
Jun 10 '24 |
Buy |
0.64 |
3,000 |
1,920 |
144,174 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):